These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

833 related items for PubMed ID: 18453022

  • 1. Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer.
    Mitchell DM, Swindell R, Elliott T, Wylie JP, Taylor CM, Logue JP.
    Radiother Oncol; 2008 Jul; 88(1):102-7. PubMed ID: 18453022
    [Abstract] [Full Text] [Related]

  • 2. PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time.
    Ciezki JP, Reddy CA, Garcia J, Angermeier K, Ulchaker J, Mahadevan A, Chehade N, Altman A, Klein EA.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):512-7. PubMed ID: 16213667
    [Abstract] [Full Text] [Related]

  • 3. Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis.
    Satoh T, Ishiyama H, Matsumoto K, Tsumura H, Kitano M, Hayakawa K, Ebara S, Nasu Y, Kumon H, Kanazawa S, Miki K, Egawa S, Aoki M, Toya K, Yorozu A, Nagata H, Saito S, Baba S.
    BJU Int; 2009 Apr 01; 103(8):1064-8. PubMed ID: 19040526
    [Abstract] [Full Text] [Related]

  • 4. [PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure].
    Toledano A, Chauveinc L, Flam T, Thiounn N, Solignac S, Timbert M, Rosenwald JC, Cosset JM.
    Cancer Radiother; 2007 May 01; 11(3):105-10. PubMed ID: 17158082
    [Abstract] [Full Text] [Related]

  • 5. PSA kinetics and PSA bounce following permanent seed prostate brachytherapy.
    Crook J, Gillan C, Yeung I, Austen L, McLean M, Lockwood G.
    Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):426-33. PubMed ID: 17869662
    [Abstract] [Full Text] [Related]

  • 6. PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: a study of 295 patients with a minimum 3-year followup.
    Toledano A, Chauveinc L, Flam T, Thiounn N, Solignac S, Timbert M, Rosenwald JC, Cosset JM.
    Brachytherapy; 2006 Oct 01; 5(2):122-6. PubMed ID: 16644467
    [Abstract] [Full Text] [Related]

  • 7. Unification of a common biochemical failure definition for prostate cancer treated with brachytherapy or external beam radiotherapy with or without androgen deprivation.
    Fitch DL, McGrath S, Martinez AA, Vicini FA, Kestin LL.
    Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1430-9. PubMed ID: 16765527
    [Abstract] [Full Text] [Related]

  • 8. Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Lief JH, Hinerman-Mulroy A, Galbreath RW.
    Brachytherapy; 2003 Dec 01; 2(3):181-8. PubMed ID: 15062141
    [Abstract] [Full Text] [Related]

  • 9. Prostate-specific antigen (PSA) bounce and other fluctuations: which biochemical relapse definition is least prone to PSA false calls? An analysis of 2030 men treated for prostate cancer with external beam or brachytherapy with or without adjuvant androgen deprivation therapy.
    Pickles T, British Columbia Cancer Agency Prostate Cohort Outcomes Initiative.
    Int J Radiat Oncol Biol Phys; 2006 Apr 01; 64(5):1355-9. PubMed ID: 16406391
    [Abstract] [Full Text] [Related]

  • 10. A prostate specific antigen (PSA) bounce greater than 1.4 ng/mL Is clinically significant after external beam radiotherapy for prostate cancer.
    Feigenberg SJ, Hanlon AL, Horwitz EM, Uzzo RG, Eisenberg D, Pollack A.
    Am J Clin Oncol; 2006 Oct 01; 29(5):458-62. PubMed ID: 17023779
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
    Miller N, Smolkin ME, Bissonette E, Theodorescu D.
    Cancer; 2005 Jun 15; 103(12):2499-506. PubMed ID: 15852361
    [Abstract] [Full Text] [Related]

  • 14. Prostate specific antigen bounce is related to overall survival in prostate brachytherapy.
    Hinnen KA, Monninkhof EM, Battermann JJ, van Roermund JG, Frank SJ, van Vulpen M.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):883-8. PubMed ID: 21300477
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. PSA bouncing after short term androgen deprivation and 3D-conformal radiotherapy for localized prostate adenocarcinoma and the relationship with the kinetics of testosterone.
    Akyol F, Ozyigit G, Selek U, Karabulut E.
    Eur Urol; 2005 Jul 01; 48(1):40-5. PubMed ID: 15967250
    [Abstract] [Full Text] [Related]

  • 18. Comparison of biochemical failure definitions for permanent prostate brachytherapy.
    Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, Moran BJ, Ciezki JP, Zietman AL, Zelefsky MJ, Pisansky TM, Elshaikh M, Horwitz EM.
    Int J Radiat Oncol Biol Phys; 2006 Aug 01; 65(5):1487-93. PubMed ID: 16750326
    [Abstract] [Full Text] [Related]

  • 19. Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer.
    Critz FA, Williams WH, Benton JB, Levinson AK, Holladay CT, Holladay DA.
    J Urol; 2000 Apr 01; 163(4):1085-9. PubMed ID: 10737471
    [Abstract] [Full Text] [Related]

  • 20. Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis.
    Horwitz EM, Levy LB, Thames HD, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Zietman AL, Kuban DA.
    Cancer; 2006 Oct 01; 107(7):1496-502. PubMed ID: 16944536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.